Back to Search

MARGARET STEIN, PA-C

PA-C

Medical Physician Assistant

NPI: 1801552047IndividualAccepts Medicare

Specialties, Licenses & Credentials

Medical Physician AssistantPrimary

Physician Assistant — Medical

Code: 363AM0700X

21169160625(MI)13708(MN)
Physician Assistant

Physician Assistant

Code: 363A00000X

13708(MN)

CMS Specialties

PrimaryPHYSICIAN ASSISTANT

Education

OTHER

Class of 2020

Clinical Trials (6)

6
Linked Trials
1
Recruiting
3
With Results

Carboxylesterase 1 Genetic Variation and Methylphenidate in ADHD

NCT03781752RECRUITINGPHASE4PRINCIPAL_INVESTIGATOR

Sequencing Treatments for Mothers With ADHD and Their At - Risk Children

NCT01816074COMPLETEDPHASE4PRINCIPAL_INVESTIGATOR

Treatments for Fathers With ADHD and Their At-Risk Children (Fathers Too)

NCT02675400COMPLETEDPHASE4PRINCIPAL_INVESTIGATOR

Stimulant Versus Nonstimulant Medication for Attention Deficit Hyperactivity Disorder in Children

NCT00183391COMPLETEDPHASE4PRINCIPAL_INVESTIGATOR

Dose Response Effects of Quillivant XR in Children With ADHD and Autism: A Pilot Study

NCT02255565COMPLETEDPHASE4PRINCIPAL_INVESTIGATOR

Basic and Clinical Research on Attention Deficit Hyperactivity Disorder (ADHD)

NCT00663442COMPLETEDPHASE4PRINCIPAL_INVESTIGATOR

Research & Publications (11)

Increased Plasma Concentrations of 6-oxo-Methylphenidate inCarriers Following a Single Oral Dose of Methylphenidate.
PMID 41567292·Med Chem Res·2025
8-other
Sequencing Stimulant Medication and Behavioral Parent Training in Multiplex ADHD Families: A Pilot SMART.
PMID 40009046·J Clin Psychiatry·2025
2-rct
Extended-release methylphenidate for attention deficit hyperactivity disorder (ADHD) in adults.
PMID 35201607·Cochrane Database Syst Rev·2022
1-meta
Acute Effects of Parent Stimulant Medication Versus Behavioral Parent Training on Mothers' ADHD, Parenting Behavior, and At-Risk Children.
PMID 32926603·J Clin Psychiatry·2020
4-observational
Striatal Activation Predicts Differential Therapeutic Responses to Methylphenidate and Atomoxetine.
PMID 28647012·J Am Acad Child Adolesc Psychiatry·2017
4-observational
Differential impact of methylphenidate and atomoxetine on sustained attention in youth with attention-deficit/hyperactivity disorder.
PMID 24942409·J Child Psychol Psychiatry·2015
4-observational
Attention-deficit hyperactivity disorder symptoms in a clinic sample of children and adolescents with pervasive developmental disorders.
PMID 17201617·J Child Adolesc Psychopharmacol·2006
8-other
ADHD symptom subtypes in children with pervasive developmental disorder.
PMID 16477513·J Autism Dev Disord·2006
8-other
Randomized, controlled, crossover trial of methylphenidate in pervasive developmental disorders with hyperactivity.
PMID 16275814·Arch Gen Psychiatry·2005
4-observational
Dopamine transporter genotype and methylphenidate dose response in children with ADHD.
PMID 15827573·Neuropsychopharmacology·2005
3-trial
A dose-response study of OROS methylphenidate in children with attention-deficit/hyperactivity disorder.
PMID 14595084·Pediatrics·2003
3-trial

Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.

Contact & Hours

Via practice · 3 locations total

Address
751 E 9 Mile Rd
Ferndale, MI 48220

Locations (3)

Practice Location

751 E 9 Mile Rd, Ferndale, MI
(248) 677-2273

Practice Location

420 Delaware St SE, Minneapolis, MN
(612) 590-1067

Practice Location

2450 RIVERSIDE AVE, MINNEAPOLIS, MN
(612) 672-6000

Quick Facts

NPI
1801552047
Entity Type
Individual
Gender
Female
Medicare
Accepted
Specialties
3
Locations
3
Years in Practice
6
Clinical Trials
6
Publications
11

Are you this provider?

Claim Your Profile